India Gelatine & Chemicals Ltd
Incorporated in 1973, India Gelatine & Chemicals Ltd is engaged in manufacturing and export of Ossein, Di-Calcium Phosphate (DCP)& Gelatine.
- Market Cap ₹ 234 Cr.
- Current Price ₹ 330
- High / Low ₹ 408 / 307
- Stock P/E 8.90
- Book Value ₹ 256
- Dividend Yield 1.51 %
- ROCE 11.9 %
- ROE 9.22 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Company is almost debt free.
- Company has delivered good profit growth of 20.4% CAGR over last 5 years
- Company has been maintaining a healthy dividend payout of 20.9%
Cons
- The company has delivered a poor sales growth of 8.52% over past five years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Commodities Chemicals Chemicals & Petrochemicals Specialty Chemicals
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 120 | 115 | 93 | 74 | 98 | 112 | 132 | 144 | 160 | 205 | 206 | 199 | 184 | |
| 105 | 109 | 89 | 74 | 96 | 107 | 124 | 135 | 152 | 172 | 171 | 177 | 152 | |
| Operating Profit | 15 | 6 | 4 | 1 | 2 | 5 | 7 | 9 | 8 | 33 | 35 | 21 | 32 |
| OPM % | 13% | 5% | 5% | 1% | 2% | 5% | 6% | 6% | 5% | 16% | 17% | 11% | 17% |
| 3 | 7 | 5 | 6 | 4 | 4 | 3 | 4 | 4 | 3 | 8 | 8 | 8 | |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 |
| Depreciation | 5 | 5 | 5 | 3 | 3 | 3 | 3 | 4 | 4 | 4 | 5 | 6 | 5 |
| Profit before tax | 12 | 7 | 5 | 3 | 3 | 6 | 6 | 9 | 7 | 32 | 37 | 23 | 34 |
| Tax % | 35% | 14% | 23% | -5% | 16% | -1% | 16% | 23% | 24% | 25% | 24% | 23% | |
| 8 | 6 | 4 | 3 | 2 | 6 | 5 | 7 | 6 | 24 | 28 | 17 | 26 | |
| EPS in Rs | 8.57 | 6.62 | 3.89 | 3.37 | 3.19 | 8.11 | 7.56 | 10.02 | 7.91 | 33.70 | 40.03 | 24.52 | 37.12 |
| Dividend Payout % | 21% | 23% | 23% | 27% | 63% | 43% | 20% | 25% | 32% | 15% | 27% | 20% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 6% |
| 5 Years: | 9% |
| 3 Years: | 7% |
| TTM: | -6% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 17% |
| 5 Years: | 20% |
| 3 Years: | 46% |
| TTM: | 58% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 16% |
| 5 Years: | 28% |
| 3 Years: | 8% |
| 1 Year: | -14% |
| Return on Equity | |
|---|---|
| 10 Years: | 8% |
| 5 Years: | 11% |
| 3 Years: | 15% |
| Last Year: | 9% |
Balance Sheet
Figures in Rs. Crores
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 9 | 9 | 9 | 9 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 |
| Reserves | 105 | 109 | 112 | 115 | 92 | 95 | 97 | 103 | 108 | 129 | 147 | 164 | 175 |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 10 | 8 | 6 | 5 | |
| 34 | 35 | 35 | 17 | 17 | 14 | 19 | 17 | 22 | 33 | 22 | 17 | 24 | |
| Total Liabilities | 148 | 154 | 157 | 141 | 115 | 116 | 124 | 127 | 136 | 180 | 184 | 195 | 211 |
| 49 | 47 | 45 | 44 | 42 | 42 | 43 | 40 | 41 | 60 | 69 | 68 | 61 | |
| CWIP | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 4 | 2 | 1 | 2 |
| Investments | 13 | 13 | 7 | 36 | 30 | 30 | 28 | 34 | 33 | 43 | 44 | 55 | 68 |
| 85 | 93 | 104 | 60 | 43 | 44 | 53 | 52 | 62 | 73 | 70 | 71 | 81 | |
| Total Assets | 148 | 154 | 157 | 141 | 115 | 116 | 124 | 127 | 136 | 180 | 184 | 195 | 211 |
Cash Flows
Figures in Rs. Crores
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -1 | 17 | 4 | -4 | 15 | 5 | 7 | 6 | 9 | 18 | 18 | 21 | |
| 2 | 3 | 8 | -27 | -19 | -1 | -3 | -6 | -8 | -21 | -8 | -17 | |
| -3 | -2 | -2 | -1 | -1 | -2 | -3 | -1 | -2 | 7 | -13 | -4 | |
| Net Cash Flow | -2 | 18 | 10 | -32 | -5 | 2 | 1 | -1 | -1 | 3 | -3 | -0 |
Ratios
Figures in Rs. Crores
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 19 | 12 | 24 | 22 | 17 | 17 | 18 | 24 | 26 | 25 | 22 | 22 |
| Inventory Days | 208 | 198 | 187 | 365 | 209 | 180 | 178 | 129 | 130 | 176 | 182 | 136 |
| Days Payable | 29 | 19 | 22 | 54 | 48 | 23 | 52 | 25 | 36 | 60 | 35 | 19 |
| Cash Conversion Cycle | 198 | 191 | 189 | 333 | 178 | 175 | 144 | 127 | 120 | 140 | 169 | 139 |
| Working Capital Days | 149 | 111 | 139 | 206 | 112 | 102 | 90 | 95 | 95 | 66 | 77 | 78 |
| ROCE % | 11% | 3% | 2% | 1% | 2% | 6% | 7% | 7% | 6% | 24% | 22% | 12% |
Documents
Announcements
-
Opening Of Special Window For Transfer And Dematerialization Of Physical Securities.
25 Feb - Opens SEBI special window Feb 5, 2026–Feb 4, 2027 for transfer/demat of pre-April 1, 2019 physical securities.
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
11 Feb - Newspaper publication - extracts of Unaudited Financial Results of the Company for the quarter ended 31st December, 2025.
-
Board Meeting Outcome for Outcome Of Board Meeting Held On 10Th February, 2026
10 Feb - Unaudited results for quarter ended 31 Dec 2025 approved; Valan Raja Nadar appointed CFO effective 10 Feb 2026.
- Board Meeting Outcome For Approval Of Un-Audited Financial Results For The Quarter Ended 31St December, 2026. 10 Feb
-
Board Meeting Intimation for Intimation Of Board Meeting Pursuant To Regulation 29 Of SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015.
30 Jan - Board meeting Feb 10, 2026 to approve unaudited results for quarter ended Dec 31, 2025; trading window closed.
Annual reports
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
Product Portfolio:[1]
a) Edible Gelatine: Being odorless & tasteless, Company's Gelatine can be mixed in any foodstuff.
b) Photographic Gelatine: This kind of gelatine has an ability to form a solution when heated and then come back to jelly form when cooled and to remain durable after water has been removed making it very useful for photographic industry.
c) Technical Gelatine: It is a good clarifying agent used in metal electrolysis. Gelatine strengthens nails and promotes hair growth therefore it is used in cosmetic industry. Also, match box industry utilizes its thickening & foaming properties to make match heads.
d) Pharmaceutical Gelatine: It is ideal for manufacture of hard & soft shell gelatine capsules. It is also used to treat wounds & as life saving blood plasma substitute.